echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Express cure rate of stomach ulcers can reach 91.4%! The FDA approved a new gastric acid inhibitor

    Express cure rate of stomach ulcers can reach 91.4%! The FDA approved a new gastric acid inhibitor

    • Last Update: 2022-09-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    ▎ WuXi AppTec content team editor

    Azurity Pharmaceuticals today announced that the U.

    Image credit: 123RF

    This time Konvomep was approved for the treatment of progressive benign stomach ulcers, mainly based on the results

    WuXi AppTec provides integrated, end-to-end new drug development and production services to the global biopharmaceutical industry, covering chemical drug development and production, biological research, preclinical and clinical trial development, cell and gene therapy research and development, testing and production

    ▲If you have any business needs, please long press to scan the QR code above, or

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.